International Money Express (IMXI) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for International Money Express in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" IMXI shares.
View IMXI analyst ratings or view top-rated stocks.

3 brokerages have issued 1-year target prices for International Money Express' shares. Their IMXI share price forecasts range from $25.00 to $35.00. On average, they anticipate the company's stock price to reach $30.75 in the next year. This suggests a possible upside of 82.0% from the stock's current price.
View analysts price targets for IMXI or view top-rated stocks among Wall Street analysts.

International Money Express' stock was trading at $24.37 at the start of the year. Since then, IMXI shares have decreased by 30.7% and is now trading at $16.90.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our IMXI earnings forecast.

International Money Express, Inc. (NASDAQ:IMXI) released its quarterly earnings data on Wednesday, August, 2nd. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.48 by $0.02. The business earned $169.15 million during the quarter, compared to analyst estimates of $171.35 million. International Money Express had a net margin of 9.33% and a trailing twelve-month return on equity of 43.09%.

ETFs with the largest weight of International Money Express (NASDAQ:IMXI) stock in their portfolio include Ballast Small/Mid Cap ETF (MGMT), Invesco Dorsey Wright Financial Momentum ETF (PFI) and ETFMG Prime Mobile Payments ETF (IPAY).Franklin Disruptive Commerce ETF (BUYZ).

International Money Express issued an update on its third quarter 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of $0.49-$0.52 for the period, compared to the consensus EPS estimate of $0.55. The company issued revenue guidance of $165.70 million-$176.80 million, compared to the consensus revenue estimate of $175.86 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other International Money Express investors own include Block (SQ), Novavax (NVAX), Advanced Micro Devices (AMD), JD.com (JD), Livongo Health (LVGO), Fastly (FSLY), Gilead Sciences (GILD), NVIDIA (NVDA), QuidelOrtho (QDEL) and Trade Desk (TTD).

International Money Express trades on the NASDAQ under the ticker symbol "IMXI."

International Money Express' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.39%), Brown Advisory Inc. (3.72%), Scopia Capital Management LP (3.32%), Voss Capital LLC (3.10%), Forager Capital Management LLC (3.04%) and Riverbridge Partners LLC (2.81%). Insiders that own company stock include Adam P Godfrey, John Rincon, Jose Perez-Villarreal, Joseph Aguilar, Justin B Wender, Michael J Purcell and Robert Lisy.
View institutional ownership trends.

Shares of IMXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of IMXI stock can currently be purchased for approximately $16.90.

International Money Express (NASDAQ:IMXI) has a market capitalization of $598.60 million and generates $546.80 million in revenue each year. The company earns $57.33 million in net income (profit) each year or $1.51 on an earnings per share basis.

The company employs 1,182 workers across the globe.

International Money Express' mailing address is 9480 S. DIXIE HIGHWAY, MIAMI FL, 33156. The official website for the company is www.corporate.intermexonline.com. The company can be reached via phone at (305) 671-8000 or via email at mgallentine@intermexusa.com.